celecoxib has been researched along with cupferron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdellatif, KR; Chowdhury, MA; Das, D; Dong, Y; Huang, Z; Knaus, EE; Suresh, MR; Velázquez, CA; Yu, G | 1 |
| Abdel Hakim, LF; Kharshoum, RM; Salem, HF; Sayed, OM | 1 |
2 other study(ies) available for celecoxib and cupferron
| Article | Year |
|---|---|
Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Design; Humans; Hydrazines; Nitric Oxide; Nitric Oxide Donors; Nitrosamines; Prodrugs; Pyrazoles; Rats; Sulfonamides | 2010 |
Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design.
Topics: Administration, Topical; Animals; Celecoxib; Drug Compounding; Drug Delivery Systems; Drug Liberation; Gels; Glycerol; Nitrosamines; Particle Size; Phospholipids; Rats; Rats, Wistar | 2018 |